Back to search
Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease trials you may qualify forThe purpose of the study CTQJ230A12304, is to evaluate the efficacy, safety, and tolerability of pelacarsen (TQJ230) compared to placebo in participants with AS…
This non-randomized, rollover extension study will provide post-trial access to pelacarsen (TQJ230) to participants who have successfully completed either of th…